AVANT Immunotherapeutics, Inc. discovers and develops innovative vaccines and therapeutics that harness the human immune system to prevent and treat disease. AVANT has three products on the market and four of AVANT's products are in clinical development. AVANT’s pipeline includes products for travelers' vaccines, global health, and pandemic flu needs based on AVANT'S rapid-protecting, single-dose, oral and temperature stable vaccine technology.

www.avantimmune.com

Top^


Gold sponsor:



Silver sponsors:





Documentation

Click here to review a comprehesive list of presentations given at Phacilitate's previous 19 Forums. All documentation is available to purchase.